Terms: = Breast cancer AND LCK, YT16, 3932, P06239, ENSG00000182866, p56lck, pp58lck AND Treatment
14 results:
1. A Machine Learning Model to Predict the Triple Negative breast cancer Immune Subtype.
Chen Z; Wang M; De Wilde RL; Feng R; Su M; Torres-de la Roche LA; Shi W
Front Immunol; 2021; 12():749459. PubMed ID: 34603338
[TBL] [Abstract] [Full Text] [Related]
2. CD151 enrichment in exosomes of luminal androgen receptor breast cancer cell line contributes to cell invasion.
Li D; Lai W; Wang Q; Xiang Z; Nan X; Yang X; Fang Q
Biochimie; 2021 Oct; 189():65-75. PubMed ID: 34157361
[TBL] [Abstract] [Full Text] [Related]
3. Biomechanical regulation of breast cancer metastasis and progression.
Spencer A; Sligar AD; Chavarria D; Lee J; Choksi D; Patil NP; Lee H; Veith AP; Riley WJ; Desai S; Abbaspour A; Singeetham R; Baker AB
Sci Rep; 2021 May; 11(1):9838. PubMed ID: 33972619
[TBL] [Abstract] [Full Text] [Related]
4. Stromal Cell Signature Associated with Response to Neoadjuvant Chemotherapy in Locally Advanced breast cancer.
Katayama MLH; Vieira RADC; Andrade VP; Roela RA; Lima LGCA; Kerr LM; Campos AP; Pereira CAB; Serio PAMP; Encinas G; Maistro S; Petroni MAL; Brentani MM; Folgueira MAAK
Cells; 2019 Dec; 8(12):. PubMed ID: 31817155
[TBL] [Abstract] [Full Text] [Related]
5. Assessment of the implant geometry in fractionated interstitial HDR breast brachytherapy using an electromagnetic tracking system.
Kellermeier M; Fietkau R; Strnad V; Bert C
Brachytherapy; 2018; 17(1):94-102. PubMed ID: 29146103
[TBL] [Abstract] [Full Text] [Related]
6. Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid cancer.
Ferrari SM; La Motta C; Sartini S; Baldini E; Materazzi G; Politti U; Ruffilli I; Ulisse S; Miccoli P; Antonelli A; Fallahi P
Mini Rev Med Chem; 2016; 16(2):86-93. PubMed ID: 26471970
[TBL] [Abstract] [Full Text] [Related]
7. Identification of Personalized Chemoresistance Genes in Subtypes of Basal-Like breast cancer Based on Functional Differences Using Pathway Analysis.
Wu T; Wang X; Li J; Song X; Wang Y; Wang Y; Zhang L; Li Z; Tian J
PLoS One; 2015; 10(6):e0131183. PubMed ID: 26126114
[TBL] [Abstract] [Full Text] [Related]
8. (-)-Liriopein B Suppresses breast cancer Progression via Inhibition of Multiple Kinases.
Wang HC; Chang FR; Huang TJ; Kuo CY; Tsai YC; Wu CC
Chem Res Toxicol; 2015 May; 28(5):897-906. PubMed ID: 25856345
[TBL] [Abstract] [Full Text] [Related]
9. Hypoxia regulation of phosphokinases and the prognostic value of pAKT in breast cancer.
Wennemers M; Stegeman H; Bussink J; Versleijen-Jonkers YM; van Laarhoven HW; Raleigh JA; Varia MA; Sweep FC; Span PN
Int J Biol Markers; 2013 Jun; 28(2):151-60. PubMed ID: 23558942
[TBL] [Abstract] [Full Text] [Related]
10. Tumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.
West NR; Milne K; Truong PT; Macpherson N; Nelson BH; Watson PH
Breast Cancer Res; 2011; 13(6):R126. PubMed ID: 22151962
[TBL] [Abstract] [Full Text] [Related]
11. Inhibition of SRC family kinases and receptor tyrosine kinases by dasatinib: possible combinations in solid tumors.
Montero JC; Seoane S; Ocaña A; Pandiella A
Clin Cancer Res; 2011 Sep; 17(17):5546-52. PubMed ID: 21670084
[TBL] [Abstract] [Full Text] [Related]
12. Systemic immune effects of adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide and/or radiotherapy in breast cancer: a longitudinal study.
Mozaffari F; Lindemalm C; Choudhury A; Granstam-Björneklett H; Lekander M; Nilsson B; Ojutkangas ML; Osterborg A; Bergkvist L; Mellstedt H
Cancer Immunol Immunother; 2009 Jan; 58(1):111-20. PubMed ID: 18488220
[TBL] [Abstract] [Full Text] [Related]
13. Hypoxia regulates cross-talk between Syk and lck leading to breast cancer progression and angiogenesis.
Chakraborty G; Rangaswami H; Jain S; Kundu GC
J Biol Chem; 2006 Apr; 281(16):11322-31. PubMed ID: 16474166
[TBL] [Abstract] [Full Text] [Related]
14. Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro.
Arnold SF; Obourn JD; Jaffe H; Notides AC
Mol Endocrinol; 1995 Jan; 9(1):24-33. PubMed ID: 7539106
[TBL] [Abstract] [Full Text] [Related]
